Related Experiment Videos
Newer antiepileptic drugs and non surgical approaches in epilepsy
1Division of Pediatric Neurology, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh.
Insights
Newer antiepileptic drugs offer improved management for one-third of children with refractory epilepsy. Specialized treatments like vigabatrin, lamotrigine, ketogenic diets, and steroids show promise for specific pediatric epilepsy syndromes.
Area of Science:
- Pediatric Neurology
- Pharmacology
Background:
- Epilepsy affects many children, with a significant portion refractory to initial treatments.
- Management of refractory childhood epilepsy requires exploring diverse therapeutic options.
Purpose of the Study:
- To review the efficacy and application of newer antiepileptic drugs (AEDs) and other therapies in pediatric epilepsy.
- To guide physicians on the rational use of these treatments.
Main Methods:
- Review of current literature on newer AEDs, ketogenic diet, steroids, and immunoglobulins for pediatric epilepsy.
- Analysis of drug indications, pharmacokinetics, and side effect profiles.
Main Results:
- Newer AEDs benefit approximately one-third of children with refractory epilepsy.
- Vigabatrin is a first-line option for infantile spasms; lamotrigine for Lennox-Gastaut Syndrome (LGS).
- Ketogenic diet and steroids show efficacy in specific syndromes like LGS and infantile spasms, respectively.
Conclusions:
- A significant subset of pediatric epilepsy cases can be managed with newer AEDs and adjunctive therapies.
- Physicians must be knowledgeable about the specific uses, pharmacokinetics, and side effects of these treatments for rational prescribing.
Abstract:
Newer antiepileptic drugs (AEDs) have helped the management of about one third of children with epilepsy who are refractory to primary AED(s). Vigabatrin and lamotrigine are being used as first line drugs for infantile spasms and Lennox Gestaut syndrome (LGS) respectively. Most of the others are, as of now, used as add-on drugs with specific indications. The ketogenic diet has been used successfully in some children with LGS. Steroids have a clear role in infantile spasms. Efficacy of immunoglobulins is mainly anecdotal. Physicians should familiarise themselves with the efficacy, pharmacokinetics and side effects of these drugs and ensure their rational use.